113 related articles for article (PubMed ID: 2236825)
1. Empiric antibiotic and antifungal therapy for granulocytopenic patients with acute leukemia.
De Rosa L; Montuoro A; De Blasio A; Della Seta R; Pacilli L; Pescador L; Petti N; De Laurenzi A
Recenti Prog Med; 1990 Jan; 81(1):37-40. PubMed ID: 2236825
[TBL] [Abstract][Full Text] [Related]
2. Empiric treatment of infections in granulocytopenic patients with acute leukemia: a study on amikacin-carbenicillin-cotrimoxazole.
Cortelezzi A; Radaelli F; Penagini R; Pogliani EM
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):520-3. PubMed ID: 6983502
[TBL] [Abstract][Full Text] [Related]
3. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
[TBL] [Abstract][Full Text] [Related]
4. [Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
Figuera A; Tomás JF; Hernández L; Jiménez ML; Peñarrubia MJ; del Rey MC; Arranz R; Cámara R; López-Lorenzo JL; Fernández-Rañada JM
Rev Clin Esp; 1996 Aug; 196(8):515-22. PubMed ID: 8984537
[TBL] [Abstract][Full Text] [Related]
5. Empiric antibiotic therapy for granulocytopenic cancer patients.
Schimpff SC
Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
[TBL] [Abstract][Full Text] [Related]
6. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
[TBL] [Abstract][Full Text] [Related]
7. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W
Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812
[TBL] [Abstract][Full Text] [Related]
8. Concept of empiric therapy with antibiotic combinations. Indications and limits.
Klastersky J
Am J Med; 1986 May; 80(5C):2-12. PubMed ID: 3521271
[TBL] [Abstract][Full Text] [Related]
9. [Bacteremia with granulocytopenia--microbiology and empiric antibiotic treatment].
Hammerstrøm J; Jacobsen T
Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4370-5. PubMed ID: 9889610
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of micafungin as an empirical antifungal agent for febrile neutropenic patients with hematological diseases.
Park JS; Kim DH; Choi CW; Jeong SH; Choi JH; Kim K; Kim SJ; Jung CW; Yang DH; Jang JH
Acta Haematol; 2010; 124(2):92-7. PubMed ID: 20664196
[TBL] [Abstract][Full Text] [Related]
11. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
Wade JC; Johnson DE; Bustamante CI
Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
Walsh TJ; Schimpff SC
Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993
[TBL] [Abstract][Full Text] [Related]
13. [Empiric therapy with piperacillin plus amikacin in febrile granulocytopenic patients with acute leukemia].
Sampi K; Kumai R; Maseki N; Sakurai M; Kaneko Y; Hattori M
Rinsho Ketsueki; 1986 Nov; 27(11):2065-9. PubMed ID: 3469434
[No Abstract] [Full Text] [Related]
14. Retrospective study of the renal effects of amphotericin B lipid complex when used at higher-than-recommended dosages and longer durations compared with lower dosages and shorter durations in patients with systemic fungal infections.
Hooshmand-Rad R; Reed MD; Chu A; Gotz V; Morris JA; Weinberg J; Dominguez EA
Clin Ther; 2004 Oct; 26(10):1652-62. PubMed ID: 15598482
[TBL] [Abstract][Full Text] [Related]
15. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.
Klastersky J; Zinner SH; Calandra T; Gaya H; Glauser MP; Meunier F; Rossi M; Schimpff SC; Tattersall M; Viscoli C
Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S35-45. PubMed ID: 3280326
[TBL] [Abstract][Full Text] [Related]
16. [Antibiotherapy in the patient with granulocytopenic cancer].
Van Der Auwera P; Meunier F
Pathol Biol (Paris); 1990 Apr; 38(4):302-6. PubMed ID: 2198526
[TBL] [Abstract][Full Text] [Related]
17. Changes in endogenous microflora among febrile granulocytopenic patients receiving empiric antibiotic therapy: implications for fungal superinfection.
Bow EJ; Louie TJ
CMAJ; 1987 Sep; 137(5):397-403. PubMed ID: 3304600
[TBL] [Abstract][Full Text] [Related]
18. [Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
Sampi K; Kumai R; Maseki N; Sakurai M; Kaneko Y; Hattori M
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):674-9. PubMed ID: 3469935
[TBL] [Abstract][Full Text] [Related]
19. [Clinical approach to infection in patients with hematologic malignancy].
Funada H
Gan To Kagaku Ryoho; 1992 Feb; 19(2):178-83. PubMed ID: 1371045
[TBL] [Abstract][Full Text] [Related]
20. Empiric antibiotic therapy with an amikacin-carbenicillin-cefoxitin combination in granulocytopenic febrile patients--a clinical report.
Fernández-Rañada J; Fernández-Garese D; Caretti D; Vázquez L; Escudero A; Olmeda F
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):511-3. PubMed ID: 6642788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]